Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-14-Speech-4-334-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-06-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20120614.22.4-334-000"2
lpv:hasSubsequent	lp_eu:2012-06-14-Speech-4-334-5002
lpv:speaker	lp:Marian Harkin2
lpv:spoken text	"The resolution on PIP is in general a positive one except where Parliament, by a small majority, voted to ask the Commission ‘to shift to a system of pre-market authorisation for medical devices of certain classes’. This makes no sense, as we already have pre-market authorisation in place for these medical devices. The PIP case has nothing – I repeat, nothing – to do with authorisation; it concerns fraud. It shows up a weakness in the process where the competent authorities did not exercise adequate controls. The problem is with market control, not with authorisation. Parliament missed the target on this one, but I was very pleased to hear Commissioner Dalli’s words to the effect that he fully recognised that the PIP case was one where the competent authorities were not consistently vigilant in regard to patient safety, and this case had nothing to do with pre-market authorisation."@en1
lpv:spokenAs	substitute; AGRI (2012-01-19--2014-06-30)3 substitute; PETI (2012-01-19--2014-06-30)3 member; Delegation for relations with the United States (2009-09-16--2014-06-30)3 unknown; - (2009-07-14--2014-06-30)3 substitute; Delegation for relations with Australia and New Zealand (2009-09-16--2014-06-30)3 member; EMPL (2012-01-19--2014-06-30)3 member_of_the_bureau; ALDE (2009-07-20--2014-06-30)3
lpv:unclassifiedMetadata	"Marian Harkin (ALDE ),"1 "in writing."1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph